For example, a recent human breast cancer study [34] used an unbiased (i.e. characterizing expression of every gene in the genome) technique, Visium, as well as droplet-based scRNA-seq to profile 26 cancer sections of various clinical subtypes including ER+ and HER2+. The gene discussed is ERBB2; the disease is breast cancer.